Oliver Schmidt

Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with TH2-driven asthma.

N. Krug, J. Hohlfeld, J. Kuhlmann, 2015, The Journal of allergy and clinical immunology.